BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robson JP, Remke M, Kool M, Julian E, Korshunov A, Pfister SM, Osborne GW, Taylor MD, Wainwright B, Reynolds BA. Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells. PLoS One 2019;14:e0210665. [PMID: 30657775 DOI: 10.1371/journal.pone.0210665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Ramezani M, Siami S, Rezaei M, Khazaei S, Sadeghi M. An immunohistochemical study of HER2 expression in primary brain tumors. Biomedicine (Taipei) 2020;10:21-7. [PMID: 33854909 DOI: 10.37796/2211-8039.1001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ni YH, Zhao X, Wang W. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy. Curr Gene Ther 2020;20:109-26. [PMID: 32576128 DOI: 10.2174/1566523220666200623170738] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Paul MR, Zage PE. Overview and recent advances in the targeting of medulloblastoma cancer stem cells. Expert Rev Anticancer Ther 2021;21:957-74. [PMID: 34047251 DOI: 10.1080/14737140.2021.1932472] [Reference Citation Analysis]